Literature DB >> 10383150

Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness.

R L Huuhtanen1, C P Blomqvist, T O Böhling, T A Wiklund, E J Tukiainen, M Virolainen, B Tribukait, L C Andersson.   

Abstract

Cyclins and cyclin-dependent kinases regulate the cell cycle. Cyclin A has a dual role in cell proliferation. It is essential in the S phase for DNA replication, and it is also involved in G2-M-phase transition, signifying actively dividing cells. The expression of cyclin A was determined by immunohistochemistry in paraffin sections of 126 soft tissue sarcomas. The median cyclin A score was 10.8% (range, 1-54%). Cyclin A expression correlated with the S-phase fraction, Ki-67 score, G2-M phase, and grade. It did not correlate with the size of the tumor. A high cyclin A score predicted a poor metastasis-free survival (P < 0.01) and a poor disease-specific overall survival (P = 0.01). We concluded that the expression of cyclin A is a powerful prognostic factor in soft tissue sarcoma. Moreover, the cyclin A score determines the fraction of tumor cells in the S phase and the G2 phase, which are the most sensitive cell cycle phases for current modalities of cancer treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383150

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation.

Authors:  W Wang; M C Caldwell; S Lin; H Furneaux; M Gorospe
Journal:  EMBO J       Date:  2000-05-15       Impact factor: 11.598

2.  Differences in protein expression and gene amplification of cyclins between colon and rectal adenocarcinomas.

Authors:  Rolf Aamodt; Kristin Jonsdottir; Solveig Norheim Andersen; Johan Bondi; Geir Bukholm; Ida R K Bukholm
Journal:  Gastroenterol Res Pract       Date:  2009-12-15       Impact factor: 2.260

3.  Involvement of cyclins in cell proliferation and their clinical implications in soft tissue smooth muscle tumors.

Authors:  T Noguchi; Y Dobashi; H Minehara; M Itoman; T Kameya
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

Review 4.  Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.

Authors:  Mitra Zabihi; Ramin Lotfi; Amir-Mohammad Yousefi; Davood Bashash
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-04       Impact factor: 4.553

5.  Prognostic significance of Minichromosome maintenance protein 7 and Geminin expression in patients with 109 soft tissue sarcomas.

Authors:  Yuki Hamamoto; Kohei Shomori; Kanae Nosaka; Tomohiro Haruki; Ryota Teshima; Hisao Ito
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

6.  Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance.

Authors:  Qi Zhou; Qiang He; Li-Jian Liang
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

7.  Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67.

Authors:  Jacob Engellau; Annette Persson; Pär-Ola Bendahl; Måns Akerman; Henryk A Domanski; Bodil Bjerkehagen; Peer Lilleng; Johan Weide; Anders Rydholm; Thor A Alvegård; Mef Nilbert
Journal:  Virchows Arch       Date:  2004-08-07       Impact factor: 4.064

8.  A Phase II Study of Flavopiridol in Patients With Previously Untreated Advanced Soft Tissue Sarcoma.

Authors:  Don G Morris; Vivien H C Bramwell; Robert Turcotte; Alvaro T Figueredo; Martin E Blackstein; Shail Verma; Sarah Matthews; Elizabeth A Eisenhauer
Journal:  Sarcoma       Date:  2006

9.  Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides.

Authors:  K Aaltonen; C Ahlin; R-M Amini; L Salonen; M-L Fjällskog; P Heikkilä; H Nevanlinna; C Blomqvist
Journal:  Br J Cancer       Date:  2006-06-05       Impact factor: 7.640

10.  Knocking-down cyclin A(2) by siRNA suppresses apoptosis and switches differentiation pathways in K562 cells upon administration with doxorubicin.

Authors:  Xiaohui Wang; Yujun Song; Jinsong Ren; Xiaogang Qu
Journal:  PLoS One       Date:  2009-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.